Advertisement

Advertisement

AU:NUZ Stock Latest News

Neurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference

Company AnnouncementsNeurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference

Neurizon steps up investor outreach with NUZ-001 ALS briefing series

PremiumCompany Announcements

Neurizon steps up investor outreach with NUZ-001 ALS briefing series

11d ago

Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX

PremiumCompany Announcements

Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX

11d ago

Neurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet

PremiumCompany Announcements

Neurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet

12d ago

Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement

PremiumCompany Announcements

Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement

21d ago

Neurizon Therapeutics Seeks ASX Quotation for 33.2 Million New Shares

PremiumCompany AnnouncementsNeurizon Therapeutics Seeks ASX Quotation for 33.2 Million New Shares

21d ago

Neurizon launches national investor briefings as ALS program enters key phase

Company Announcements

Neurizon launches national investor briefings as ALS program enters key phase

25d ago

Neurizon Raises A$2.7m via Entitlement Offer Shortfall to Advance ALS Drug NUZ-001

Company Announcements

Neurizon Raises A$2.7m via Entitlement Offer Shortfall to Advance ALS Drug NUZ-001

26d ago

Neurizon issues shares for investor relations as it advances ALS-focused pipeline

PremiumCompany Announcements

Neurizon issues shares for investor relations as it advances ALS-focused pipeline

1M ago

Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares

PremiumCompany Announcements

Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares

1M ago

Neurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models

PremiumCompany Announcements

Neurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models

1M ago

Neurizon Director Increases Stake Through $150,000 Share Placement

PremiumCompany Announcements

Neurizon Director Increases Stake Through $150,000 Share Placement

2M ago

Neurizon Sets April 2026 Expiry for NUZOA Listed Options

PremiumCompany AnnouncementsNeurizon Sets April 2026 Expiry for NUZOA Listed Options

2M ago

Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar

Company Announcements

Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar

2M ago

Neurizon Issues Director Shares, Affirms Compliance and Transparency

Company Announcements

Neurizon Issues Director Shares, Affirms Compliance and Transparency

2M ago

Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares

PremiumCompany Announcements

Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares

2M ago

Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor

PremiumCompany Announcements

Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor

2M ago

Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026

PremiumCompany Announcements

Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026

2M ago

Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang

PremiumCompany Announcements

Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang

2M ago

Neurizon Draws First $5m Tranche to Advance ALS Drug Trial

PremiumCompany AnnouncementsNeurizon Draws First $5m Tranche to Advance ALS Drug Trial

2M ago

Neurizon Taps A$5m in Convertible Note Funding From Obsidian

Company Announcements

Neurizon Taps A$5m in Convertible Note Funding From Obsidian

2M ago

Neurizon issues 10m shares under convertible note, affirms compliance and disclosure

Company Announcements

Neurizon issues 10m shares under convertible note, affirms compliance and disclosure

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >